Skip to main content

TLX · Telix Pharmaceuticals Ltd · Analyst Estimates

Track TLX — free
$10.80 +0.25 (+2.37%) At close · Oct 5
Market Cap
$3.88B
Shares
338.78M
Volume · Oct 5 235.31K Avg daily vol (3M) 247.58K

Analyst Estimates

Compare analyst forecasts for Telix Pharmaceuticals Ltd across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-05 16:50 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
AUD
Publication date not stated
0.029
0.1486
0.394
—
0.1546
0.0922
0.1482
0.1327
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
1
0
3
3
Revenue
AUD
Publication date not stated
1358591000
1385584140
1444596000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
16
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
AUD
Publication date not stated
-0.045
-0.038
-0.031
—
0.2035
0.28825
0.051
0.33475
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
1
0
0
0
Revenue
AUD
Publication date not stated
1486647000
1576826100
1759782000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
AUD
Publication date not stated
0.07
0.07
0.07
—
0.0
0.014
0.0
0.043
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
1
1
Revenue
AUD
Publication date not stated
276233000
312023300
347813610
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
2
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
AUD
Publication date not stated
0.07
0.07
0.07
—
0.0
0.0
0.0
0.043
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
1
1
0
Revenue
AUD
Publication date not stated
267820000
310002820
352185630
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
2
— — — — — — — —
Key facts CIK 2007191 CUSIP 87961M105 13F (30d) 1 filings 1 filers Visit website Investor relations